University of Rochester Vaccines to Prevent HIV Infection CRS — New York, New York

University of Rochester Vaccines to Prevent HIV Infection CRS is a clinical research site located in New York, New York, United States 14642.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Rochester Vaccines to Prevent HIV Infection CRS has participated in 1 clinical trials.

Therapeutic areas: HIV Infections.

Sponsors: HIV Vaccine Trials Network.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester Vaccines to Prevent HIV Infection CRS?

University of Rochester Vaccines to Prevent HIV Infection CRS has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester Vaccines to Prevent HIV Infection CRS conducted?

University of Rochester Vaccines to Prevent HIV Infection CRS has 1 clinical trials on record. Their work covers HIV Infections.

Is University of Rochester Vaccines to Prevent HIV Infection CRS accredited by Crixeo Health?

University of Rochester Vaccines to Prevent HIV Infection CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester Vaccines to Prevent HIV Infection CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.